- Home
- NBIX vs EMN Comparison
NBIX vs EMN Comparison
Compare NBIX & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- EMN
- Stock Information
- Founded
- NBIX 1992
- EMN 1920
- Country
- NBIX United States
- EMN United States
- Employees
- NBIX 1448
- EMN N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- EMN Major Chemicals
- Sector
- NBIX Health Care
- EMN Industrials
- Exchange
- NBIX Nasdaq
- EMN Nasdaq
- Market Cap
- NBIX 11.8B
- EMN 12.9B
- IPO Year
- NBIX 1996
- EMN 1993
- Fundamental
- Price
- NBIX $117.44
- EMN $101.59
- Analyst Decision
- NBIX Buy
- EMN Buy
- Analyst Count
- NBIX 24
- EMN 14
- Target Price
- NBIX $163.91
- EMN $111.50
- AVG Volume (30 Days)
- NBIX 1.0M
- EMN 1.0M
- Earning Date
- NBIX 10-30-2024
- EMN 10-31-2024
- Dividend Yield
- NBIX N/A
- EMN 3.19%
- EPS Growth
- NBIX 97.40
- EMN 52.51
- EPS
- NBIX 3.73
- EMN 7.47
- Revenue
- NBIX $2,242,800,000.00
- EMN $9,344,000,000.00
- Revenue This Year
- NBIX $26.97
- EMN $3.15
- Revenue Next Year
- NBIX $16.69
- EMN $4.31
- P/E Ratio
- NBIX $31.50
- EMN $13.61
- Revenue Growth
- NBIX 25.72
- EMN N/A
- 52 Week Low
- NBIX $108.14
- EMN $80.71
- 52 Week High
- NBIX $157.98
- EMN $114.50
- Technical
- Relative Strength Index (RSI)
- NBIX 42.69
- EMN 41.49
- Support Level
- NBIX $119.08
- EMN $100.11
- Resistance Level
- NBIX $129.67
- EMN $103.09
- Average True Range (ATR)
- NBIX 3.34
- EMN 2.09
- MACD
- NBIX -0.02
- EMN -0.23
- Stochastic Oscillator
- NBIX 14.59
- EMN 39.18
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
About EMN Eastman Chemical Company
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.